Mulmit

Zymeworks Inc.Zymeworks Inc.

ZYME Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31105,965,000-92,549,000-81,130,000-1.08
2024-12-3176,304,000-137,110,000-122,695,000-1.62
2023-12-3176,012,000-138,053,000-118,674,000-1.72
2022-12-31412,482,000130,528,000124,341,0001.9
2021-12-3126,680,000-215,633,000-211,843,000-4.61

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-06Hollywood MarkEVP & Chief Operating Officer939
2026-05-13Schneider Paul REVP, General Counsel178,000
2026-05-13Schneider Paul REVP, General Counsel119,000
2026-04-09Schayowitz AdamSee Remarks70,000
2026-04-09Schayowitz AdamSee Remarks47,000
2026-04-09Schayowitz AdamSee Remarks76,000
2026-04-09Platshon ScottEVP, Chief Business Officer70,000
2026-04-09Platshon ScottEVP, Chief Business Officer47,000
2026-04-09Platshon ScottEVP, Chief Business Officer76,000
2026-04-06Stafford KristinEVP, Chief Financial Officer178,000
2026-04-06Stafford KristinEVP, Chief Financial Officer119,000
2026-04-06Stafford KristinEVP, Chief Financial Officer50,000

8-K events

FiledItems
2026-08-25Regulation FD disclosure · Other events · Financial statements and exhibits
2026-08-06Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-06-29Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
2026-05-14Regulation FD disclosure · Other events · Financial statements and exhibits
2026-05-07Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-04-01Officer or director change · Financial statements and exhibits
2026-03-02Entry into a material agreement · Creation of a direct financial obligation · Regulation FD disclosure · Financial statements and exhibits
2026-03-02Results of operations · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.